Subhransu Ray

Title: Subhransu Ray: Innovating Monoclonal Antibody Production

Introduction

Subhransu Ray, an accomplished inventor based in the Bronx, NY, has made significant contributions to the field of biomedical research. He is known for his innovative work on a hybridoma-producing NSO myeloma cell line, which has potential implications for the development of monoclonal antibodies.

Latest Patents

Subhransu Ray holds one patent for his invention: the Hybridoma-producing NSO myeloma cell line. This invention enhances the fusion frequency of NSO myeloma cell lines, leading to the production of monoclonal antibodies with increased resistance to cell death. The hybridomas generated through this process secrete antibodies that exhibit heightened affinity for both foreign antigens and autoantigens, marking a significant advancement in immunological research.

Career Highlights

Ray has established a commendable career in the medical and research fields, currently working at the Albert Einstein College of Medicine. His research focuses on enhancing cell fusion techniques, which are pivotal in generating effective hybridomas for therapeutic uses.

Collaborations

Throughout his career, Subhransu Ray has worked alongside notable scientists, including his colleague Betty A. Diamond. These collaborations have fostered innovative ideas and have been instrumental in advancing the research surrounding monoclonal antibody production.

Conclusion

Subhransu Ray's contributions to the field of biotechnology through his patented invention represent a fruitful intersection of innovation and scientific inquiry. His work not only paves the way for enhanced monoclonal antibody production but also underscores the importance of collaboration in scientific advancements. As he continues his research, the potential for further developments in therapeutic applications remains promising.